Actively Recruiting
Effect of Sex on Orthostatic Intolerance and Cardiovascular Response During Lunar Descent and Ascent
Led by National Aeronautics and Space Administration (NASA) · Updated on 2025-04-01
38
Participants Needed
1
Research Sites
159 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of Lunar OI (Orthostatic Intolerance) is to determine if there are differences between males and females in tolerance to and cardiovascular responses during different angles of head-up tilt simulating gravity levels less than or equal to Earth's gravity. Also, this study will determine if a gradient compression garment affects tolerance to tilting and the cardiovascular stress at different tilt angles. Males and females are being identified by biological sex. This will be a two-phased study design. In Phase I we will determine whether there are differences in the development of signs or symptoms of orthostatic intolerance between males and females when tilted head up on a table to different angles to simulate gravity levels that astronauts may experience when landing on or launching from the surface of the Moon. In Phase II, the tilt tests simulating the same gravity levels from Phase I will be repeated, but a custom-made lower-body compression garment will be worn to see if wearing the garment affects the development of orthostatic intolerance. For both study phases, before tilting, a drug will be administered to reduce the amount fluid in the blood (plasma) to levels similar to that experienced by astronauts during spaceflight.
CONDITIONS
Official Title
Effect of Sex on Orthostatic Intolerance and Cardiovascular Response During Lunar Descent and Ascent
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pass a test subject screening facility modified Air Force Class III physical
You will not qualify if you...
- Known allergy to furosemide or sulfa drugs
- Currently taking drugs or medications known to adversely interact with furosemide, including but not limited to aspirin, NSAIDs, antibiotics, or immunosuppressant drugs
- Systemic diseases or current medications known to influence the cardiovascular system
- Renal disease
- Type II Diabetes
- Pregnant participants will be excluded (a urine pregnancy screen will be made available).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NASA
Houston, Texas, United States, 77058
Actively Recruiting
Research Team
J
Jason R Lytle, PhD
CONTACT
L
Lucinda M Yu, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here